XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK-BASED COMPENSATION
3 Months Ended
Sep. 30, 2022
Equity [Abstract]  
STOCK-BASED COMPENSATION

 

6. STOCK-BASED COMPENSATION

 

Stock Options

 

The following table summarizes stock-based compensation expense for the three months ended September 30, 2022 and 2021: The share amounts and prices shown below do not reflect adjustment for a 1-for-3 reverse stock split that took effect after the close of business on November 1, 2022.

        
   Three Months
Ended September 30,
 
   2022   2021 
Cost of Goods Sold  $6,298   $28,415 
Research and Development Expenses   30,756    43,489 
Selling, General and Administrative Expenses   37,936    88,167 
   $74,990   $160,071 

 

No compensation has been capitalized because such amounts would have been immaterial.

  

The following tables summarize stock option activity for the three months ended September 30 2022:

               
    Options Outstanding 
    Number of
Shares
    Weighted Average
Exercise Price
    Weighted Average
Contractual Life
 
Outstanding at June 30, 2022   2,714,000   $1.33    7.08 years 
Exercised, Granted and Cancelled            
Outstanding at September 30, 2022   2,714,000   $1.33    6.83 years 

 

Information related to the stock options outstanding as of September 30, 2022 is as follows:

                                           
Range of
Exercise Prices
    Number of
Shares
    Weighted-
Average
Remaining
Contractual Life
(years)
    Weighted-
Average
Exercise Price
    Exercisable
Number of
Shares
    Exercisable
Weighted-
Average
Exercise Price
 
$ 0.48       60,000       3.50     $ 0.48       60,000     $ 0.48  
$ 0.50       80,000       3.72     $ 0.50       80,000     $ 0.50  
$ 0.55       15,000       5.51     $ 0.55       15,000     $ 0.55  
$ 0.70       100,000       5.84     $ 0.70       100,000     $ 0.70  
$ 0.73       630,000       4.41     $ 0.73       630,000     $ 0.73  
$ 0.85       6,000       0.26     $ 0.85       6,000     $ 0.85  
$ 0.90       36,000       1.69     $ 0.90       36,000     $ 0.90  
$ 1.25       45,000       7.47     $ 1.25       30,000     $ 1.25  
$ 1.30       441,000       6.70     $ 1.30       431,500     $ 1.30  
$ 1.40       70,000       8.13     $ 1.40       70,000     $ 1.40  
$ 1.42       100,000       6.95     $ 1.42       100,000     $ 1.42  
$ 1.45       5,000       8.44     $ 1.45       1,667     $ 1.45  
$ 1.50       70,000       7.19     $ 1.50       70,000     $ 1.50  
$ 1.68       540,000       8.68     $ 1.68       540,000     $ 1.68  
$ 1.87       30,000       9.61     $ 1.87           $  
$ 2.00       100,000       8.57     $ 2.00       10,000     $ 2.00  
$ 2.09       246,000       9.36     $ 2.09           $  
$ 2.26       140,000       9.14     $ 2.26       90,000     $ 2.26  
$ 0.482.26       2,714,000       6.83     $ 1.33       2,270,167     $ 1.20  

 

The aggregate intrinsic value of the Company’s in-the-money outstanding and exercisable options as of September 30, 2022 was $1,982,850 and $1,951,825, respectively.